z-logo
open-access-imgOpen Access
COMMON DEFICIENCIES RAISED BY VARIOUS REGULATORY AGENCIES
Author(s) -
S. Mohidekar,
V. Maharao,
Jitendra Kumar Badjatya
Publication year - 2018
Publication title -
international journal of drug regulatory affairs
Language(s) - English
Resource type - Journals
eISSN - 2321-7162
pISSN - 2321-6794
DOI - 10.22270/ijdra.v2i2.125
Subject(s) - drug development , business , drug , product (mathematics) , closure (psychology) , new product development , medicine , political science , pharmacology , law , marketing , geometry , mathematics
Timely Product registration is a challenge in today’s scenario. Regulatory agencies are keen in assessing CTD sections like redefining starting material of Drug substance manufacturing, Pharmaceutical development, impurities in Drug substance and Drug product, Container-closure. Common deficiencies are presented in this article.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here